Chapter
Chapter 11 Therapeutic targets based on the modulation of immune function by gut bacteria
Abstract
The only current therapy in celiac disease (CeD) is a lifetime gluten-free diet. Although this intervention is safe and effective in most patients, there are limitations that warrant the development of adjuvant therapies to improve clinical outcomes. Recent studies support the hypothesis that viral infections and bacterial opportunistic pathogens play a role in CeD by affecting inflammatory and metabolic pathways. Knowledge of mechanistic …
Authors
Caminero A; Verdu EF
Book title
Biotechnological Strategies for the Treatment of Gluten Intolerance
Pagination
pp. 221-237
Publisher
Elsevier
Publication Date
2021
DOI
10.1016/b978-0-12-821594-4.00004-9